In 2003, billionaires Rebecka Belldegrun and Arie Belldegrun launched Bellco Capital. Arie Belldegrun is an Israeli-American oncologist that founded Agensys in 1996 and Cougar Biotechnology in 2003. Both companies were sold for hundreds of millions of dollars. Bellco Capital is a direct investment firm that focuses on deploying capital to create and support companies with bold ambitions of exponential transformation in life science, real estate, consumer products, media, and other sectors. The life science portfolio of the family office consists of firms like Cell Design Labs, Kite Pharma and Neogene Therapeutics. Our keyword crawler found a biotech keyword rate of 2% on the Bellco Capital website. Neogene Therapeutics is a preclinical biotechnology firm working on T cell therapies for cancers. The oncology startup was launched in September 2018 by stem cell researchers Ton Schumacher and Carsten Linnemann.
Browse more single family office (sfo)s and other institutional investors by location and type in the LPbacked limited-partner database.
Bellco Capital is a single family office (sfo) based in Los Angeles, United States, managing approximately $450M in assets.
Bellco Capital is headquartered in Los Angeles, United States.
Bellco Capital manages approximately $450M in assets under management.
Bellco Capital focuses on Bridge Financing, Direct Investing, Distressed Debt Investing, Investment Funds, Joint Venture/Partner, Junior/Mezzanine Financing, Management Buyout, Mergers & Acquisitions/Buyouts.
Verified contact details, key decision-makers, and investment preferences for Bellco Capital are available on LPbacked. Create a free account to access them.